24 November 2020 in Neural Plasticity
Ras-related C3 botulinum toxin substrate 1 (Rac1) is a small GTPase that is well known for its sensitivity to the environmental stress of a cell or an organism. It senses the external signals which are transmitted from membrane-bound receptors and induces downstream signaling cascades to exert its physiological functions. Rac1 is an important regulator of a variety of cellular processes, such as cytoskeletal organization, generation of oxidative products, and gene expression. In particular, Rac1 has a significant influence on certain brain functions like neuronal migration, synaptic plasticity, and memory formation via regulation of actin dynamics in neurons. Abnormal Rac1 expression and activity have been observed in multiple neurological diseases. Here, we review recent findings to delineate the role of Rac1 signaling in neurodevelopmental disorders associated with abnormal spine morphology, synaptogenesis, and synaptic plasticity. Moreover, certain novel inhibitors of Rac1 and related pathways are discussed as potential avenues toward future treatment for these diseases.
25 May 2021 in Research Square
INTRODUCTION: An Amyand’s hernia is a heterogeneous clinical condition defined by the presence of the vermiform appendix within an inguinal hernia sac, which may or may not contain other abdominal contents or pathologic inflammatory changes. Herein we present an exceptionally rare case of an Amyand’s hernia containing a suppurative appendix and omentum on a morbidity obesity patient , in order to improve our understanding of this disease, avoid misdiagnosis and share experience in the treatment. PRESENTATION OF CASE: A 46-year-old morbidity obesity male presented to our Emergency Department complained an acute onset abdominal pain near the right groin and the McBurney point with nausea and fever. The patient was initially diagnosed as acute appendicitis according to the laboratory tests and the clinical presentation. However, after a right groin hernia contained an inflamed appendix showed by the computed tomography scan, the final diagnosis of Amyand’s hernia was supported. Surgical treatment was then performed, and a right groin hernia was found to contain a suppurative appendix and omentum, intraoperatively. An appendectomy was performed, but the hernia was not repaired simultaneously considering the morbidity risks and surgically technical difficulty brought with the severe morbidity obesity. CONCLUSION: With an estimated incidence of only 1%, Amyand’s hernias are rare emergency case, lacking a clear evidence-based management scheme. Moreover, they can contain a diverse range of pathologic features and presentations that can complicate diagnosis and treatment. There is a paucity of reports describing the management of an Amyand’s hernia with appendicitis on morbidity obesity patients. In our case, we shared our surgical experience and the management of Amyand’s hernia on morbidity obesity patient should be tailored to individual’s condition.
11 April 2025 in Discover Medicine
Background Neuroendocrine neoplasms (NENs) of the gallbladder (GB) are rare, accounting for approximately 0.5% of all NENs. Neuroendocrine-non-neuroendocrine neoplasm (MiNEN) is a rare two-part tumor with a poor prognosis. Currently, there is no clear treatment strategy or management guideline. Case presentation A 77-year-old male was admitted to Xuanwu Hospital after a physical examination revealed ten days of thickening of the gallbladder floor detected during a physical examination. Laboratory examinations raised suspicion of malignant tumors, and subsequent pathological diagnosis confirmed MiNENs of the gallbladder (GB-MiNENs) following surgical resection. Eleven months after discharge, follow-up CT revealed multiple intrahepatic masses indicating liver metastasis. After that, the patient initiated systemic therapy with sintilimab with surufatinib and achieved stable disease. However, treatment was interrupted because of COVID-19 infection after three cycles. A reexamination via abdominal CT revealed an increase in liver lesion size. Therefore, treatment with sintilimab resumed accordingly, and treatment with surufatinib resumed once the infection improved. After seven cycles of treatment, the patient was readmitted due to heart failure caused by COVID-19 infection and unfortunately died seven months later following liver metastasis treatment completion. Conclusions The exploratory treatment of this case provides some reference value for the treatment of GB-MiNEN patients who have metastasized to the liver after laparoscopic radical cholecystectomy.
6 May 2022 in Anz Journal of Surgery